In short, these data imply that KRT7-AS reduces expression of oncogenic KRT7 and downstream tumorigenic FOXA1 in cancer tissues and cells, implying that inhibition of oncogenic KRT7 and FOXA1 is one of the mechanisms underlying KRT7-AS-mediated tumor suppression and pro-apoptosis. The gene discussed is KRT7; the disease is cancer.